CRISPR Therapeutics AG - Common Shares (NQ:CRSP)

These stocks are steals right now.

Check Out What Whales Are Doing With CRSP ↗

February 14, 2024

Via Benzinga

$1000 Invested In This Stock 5 Years Ago Would Be Worth $2,300 Today ↗

February 09, 2024

Via Benzinga

Got $100? 2 Top Cathie Wood Stocks to Buy and Hold. ↗

February 04, 2024

The outlook for growth has made biotech one of the hottest investments of late - and Wall Street sees big comeback gains ahead in these two biotechs.

If You Invested $100 In This Stock 5 Years Ago, You Would Have $200 Today ↗

January 22, 2024

Via Benzinga

Analysts see over 50% gains in these 2 mid-cap biotech stocks

February 14, 2024

CRISPR Therapeutics shows improving price performance, earning an upgrade to its IBD Relative Strength Rating.

Topics Artificial Intelligence

CRISPR Therapeutics Stock Shows Rising Relative Strength, Hits 90+ ↗

February 13, 2024

Via Investor's Business Daily

3 Gene Editing Stocks With Unprecedented Surge Potential ↗

February 13, 2024

While CRISPR will certainly be exciting to watch, here are some other gene-editing stocks with unprecedented surge potential.

The famous investor owns some huge winners -- and big losers, too.

Cathie Wood Has 37% of Her Ark Invest Portfolio Invested in These 7 Stocks ↗

February 12, 2024

CRISPR Therapeutics shares have soared 39% over the past three months.

Could CRISPR Therapeutics Stock Help You Become a Millionaire? ↗

January 22, 2024

Get the latest investment advice for healthcare stocks in 2024. Discover top picks and growth opportunities for the healthcare sector.

3 Groundbreaking Healthcare Stocks to Buy for Robust Gains ↗

February 11, 2024

These strong buy healthcare stocks are among analysts' favorite picks, and their strong market position tells us why.

3 Strong Buy Healthcare Stocks to Add to Your February Must-Watch List ↗

February 09, 2024

With patience, some of the most undervalued biotech stocks can create massive wealth, such as these three to consider.

The 3 Most Undervalued Biotech Stocks to Buy in February 2024 ↗

February 08, 2024

Both companies are proven innovators.

2 Healthcare Stocks to Buy Hand Over Fist in February ↗

February 08, 2024

They aren't all long shots, but they're all innovative.

Cathie Wood Just Bought These 3 Biotech Stocks. Should You? ↗

February 07, 2024

These two Cathie Wood holdings are great long-term buys.

2 Cathie Wood Stocks I Plan on Buying for My Kids' Portfolios ↗

February 05, 2024

Discover how emerging tech is shaping healthcare stocks in 2024. See which companies are outperforming and what it means for your portfolio.

Top Stock Picks 2024: 3 Healthcare Stocks Leading Medical Advancements ↗

February 01, 2024

On CNBC’s "Mad Money Lightning Round," Jim Cramer said he is taking a "hard pass" on Surgery Partners, Inc. (NASDAQ: SGRY). "That industry has been up and down and up and down," he added.

Jim Cramer Says It's 'Still Not Too Late' To Buy This Energy Stock ↗

January 31, 2024

Via Benzinga

History Says the S&P 500 May Climb in the Triple Digits During This Bull Market. 3 Top Growth Stocks to Buy Before it Does. ↗

January 30, 2024

Bull markets generally favor growth stocks, so now is a great time to buy quality growth players.

CRISPR Therapeutics is a specialist in the hot technology of gene editing.

Topics Stocks

Is CRISPR Therapeutics a Buy in the New Bull Market? ↗

January 30, 2024

Wood added to her existing positions in these three exciting companies.

Cathie Wood Goes Bargain Hunting: 3 Stocks She Bought Last Week ↗

January 28, 2024

These biotech stocks offer exciting and disruptive solutions with the potential to expand to market caps worth trillions.

Biotech Stocks Are on Fire: Here Are the Top 3 Picks for January ↗

January 25, 2024

Affirm, MongoDB, UIPath, Synopsys and Crispr's charts signal buy opportunities as these top-performing tech and biotech stocks consolidate below prior highs.

These 5 growth stocks are now in buy ranges

January 25, 2024

The company could maintain the momentum it gained last year.

Topics ETFs

Where Will CRISPR Therapeutics Be in 5 Years? ↗

January 24, 2024

Despite A bump in the road, the biotech's future looks sunny.

1 Setback and 1 Opportunity for CRISPR Therapeutics Stock ↗

January 23, 2024

Gene therapy is receiving much of the spotlight in the medical sector in 2024. The FDA approval for Casgevy, Vertex Pharmaceuticals Inc. (NASDAQ: VRTX)

2 gene editing stocks to keep on your 2024 watchlist

January 23, 2024

If You Invested $10,000 in Vertex Pharmaceuticals in 2018, This Is How Much You Would Have Today ↗

January 22, 2024

Has investing in Vertex been a better option than just putting your money in the S&P 500?

Cathie Wood's Flagship ARKK ETF Is Taking On Water Due To Coinbase, Tesla, These Stocks ↗

Topics Stocks

January 22, 2024

The flagship ETF's top holdings are down in 2024, especially No. 1 Coinbase.

Via Investor's Business Daily

Topics ETFs

Could Editas Medicine Become the Next CRISPR Therapeutics? ↗

January 21, 2024